Home > Financial Ratios > SURAKSHA DIAGNOSTIC

SURAKSHA DIAGNOSTIC
Core EBITDA Growth

    Back to All Ratios
SURAKSHA DIAGNOSTIC is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for SURAKSHA DIAGNOSTIC
Please provide your vote to see the results

SURAKSHA DIAGNOSTIC Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 55.14-4.78110.05-32.7053.35

What is the latest Core EBITDA Growth ratio of SURAKSHA DIAGNOSTIC ?

The latest Core EBITDA Growth ratio of SURAKSHA DIAGNOSTIC is 55.14 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202455.14
Mar2023-4.78
Mar2022110.05
Mar2021-32.70
Mar202053.35

How is Core EBITDA Growth of SURAKSHA DIAGNOSTIC Trending?

Years Core EBITDA Growth % Change
Mar2024 55.14
Positive
Mar2023 -4.78
Negative
Mar2022 110.05
Positive
Mar2021 -32.7
Negative
Mar2020 53.35 -

Other Financial Ratios of SURAKSHA DIAGNOSTIC


Compare Core EBITDA Growth ratio of peers of SURAKSHA DIAGNOSTIC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SURAKSHA DIAGNOSTIC ₹1,558.1 Cr -3.8% 12.7% NA Stock Analytics
MAX HEALTHCARE INSTITUTE ₹106,566.0 Cr -1% -2.4% 37.9% Stock Analytics
APOLLO HOSPITALS ENTERPRISE ₹100,104.0 Cr -2.8% 6.8% 9.5% Stock Analytics
FORTIS HEALTHCARE ₹51,839.2 Cr 2.8% 6.4% 50.6% Stock Analytics
NARAYANA HRUDAYALAYA ₹35,940.9 Cr -2.1% 7.9% 40.2% Stock Analytics
GLOBAL HEALTH ₹32,188.8 Cr -3.5% -1.9% -18.2% Stock Analytics


SURAKSHA DIAGNOSTIC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SURAKSHA DIAGNOSTIC

-3.8%

12.7%

NA
SENSEX

0.2%

2.9%

8.7%


You may also like the below Video Courses